Recent work done in our laboratory found that Akt was constitutively activated in GH3 adenoma cells, as was observed in human pituitary tumors, and that attenuation of this signaling pathway significantly reduced cellular viability. The gene discussed is AKT1; the disease is pituitary tumor.